These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127. Bernardi S; Farina M; Zanaglio C; Cattina F; Polverelli N; Schieppati F; Re F; Foroni C; Malagola M; Dunbar AJ; Russo D Case Rep Hematol; 2020; 2020():2795656. PubMed ID: 32148977 [TBL] [Abstract][Full Text] [Related]
128. Identification of new ETV6 modulators through a high-throughput functional screening. Neveu B; Richer C; Cassart P; Caron M; Jimenez-Cortes C; St-Onge P; Fuchs C; Garnier N; Gobeil S; Sinnett D iScience; 2022 Mar; 25(3):103858. PubMed ID: 35198911 [No Abstract] [Full Text] [Related]
129. The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression. Powers MP Oncogene; 2019 Nov; 38(47):7197-7199. PubMed ID: 31616060 [No Abstract] [Full Text] [Related]
130. Expanding the spectrum of cancer targets by predicting individual gene fusions. Nat Biotechnol; 2022 Aug; 40(8):1188-1189. PubMed ID: 35383308 [No Abstract] [Full Text] [Related]
131. Cell fusion in cancer hallmarks: Current research status and future indications. Wang HF; Xiang W; Xue BZ; Wang YH; Yi DY; Jiang XB; Zhao HY; Fu P Oncol Lett; 2021 Jul; 22(1):530. PubMed ID: 34055095 [TBL] [Abstract][Full Text] [Related]
132. Mapping the cancer cell states conserved across solid tumors. Roden D; Swarbrick A Nat Genet; 2022 Aug; 54(8):1066-1067. PubMed ID: 35931862 [No Abstract] [Full Text] [Related]
133. Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL). Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288 [TBL] [Abstract][Full Text] [Related]
134. The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations. Kinnunen M; Liu X; Niemelä E; Öhman T; Gawriyski L; Salokas K; Keskitalo S; Varjosalo M Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686522 [TBL] [Abstract][Full Text] [Related]
135. Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation. Sivakumar S; Moore JA; Montesion M; Sharaf R; Lin DI; Colón CI; Fleishmann Z; Ebot EM; Newberg JY; Mills JM; Hegde PS; Pan Q; Dowlati A; Frampton GM; Sage J; Lovly CM Cancer Discov; 2023 Jul; 13(7):1572-1591. PubMed ID: 37062002 [TBL] [Abstract][Full Text] [Related]
136. BCL-G: 20 years of research on a non-typical protein from the BCL-2 family. Hartman ML; Czyz M Cell Death Differ; 2023 Jun; 30(6):1437-1446. PubMed ID: 37031274 [TBL] [Abstract][Full Text] [Related]
137. ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation. Gao Y; He XY; Wu XS; Huang YH; Toneyan S; Ha T; Ipsaro JJ; Koo PK; Joshua-Tor L; Bailey KM; Egeblad M; Vakoc CR Nat Cell Biol; 2023 Feb; 25(2):298-308. PubMed ID: 36658219 [TBL] [Abstract][Full Text] [Related]
138. ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia. Kodgule R; Goldman JW; Monovich AC; Saari T; Aguilar AR; Hall CN; Rajesh N; Gupta J; Chu SA; Ye L; Gurumurthy A; Iyer A; Brown NA; Chiang MY; Cieslik MP; Ryan RJH Blood Cancer Discov; 2023 Jan; 4(1):34-53. PubMed ID: 36350827 [TBL] [Abstract][Full Text] [Related]
139. Acute myeloid leukemia with an Rosenzweig J; Pillai PM; Prockop S; Benayed R; Eidenschink Brodersen L; Najfeld V; Loken MR; Zhang Y; Shukla N Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483876 [TBL] [Abstract][Full Text] [Related]
140. t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity. Mueller SB; Dal Cin P; Le LP; Dias-Santagata D; Lennerz JK; Iafrate AJ; Marble HD; Brunner AM; Weinstock MJ; Luskin MR; De Angelo DJ; Stone RM; Nardi V Blood Adv; 2022 Jan; 6(3):818-827. PubMed ID: 34587239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]